Literature DB >> 28779646

In vivo reprogramming for tissue regeneration and organismal rejuvenation.

Jumpei Taguchi1, Yasuhiro Yamada2.   

Abstract

Transcription factor-mediated reprogramming has enabled us to induce the fate conversion of somatic cells into other cell types. Although the study of reprogramming mostly occurs at the cellular level in vitro, previous studies have demonstrated that somatic cells are reprogrammable in multicellular organisms too. Recent studies using in vivo reprogramming have provided important insights on regenerative medicine for diseased organs. Moreover, similar studies have revealed unappreciated mechanisms in various biological phenomena, including tissue regeneration, aging, rejuvenation and cancer development in multicellular organisms. Here, we review recent progress and future perspectives of in vivo reprogramming.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28779646     DOI: 10.1016/j.gde.2017.07.008

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  9 in total

Review 1.  In Vivo Transient and Partial Cell Reprogramming to Pluripotency as a Therapeutic Tool for Neurodegenerative Diseases.

Authors:  S Tamanini; G P Comi; S Corti
Journal:  Mol Neurobiol       Date:  2018-01-20       Impact factor: 5.590

2.  Identification of microRNAs related with neural germ layer lineage-specific progenitors during reprogramming.

Authors:  Ruizhen Sun; Tiantian Gong; Hui Liu; Jingling Shen; Bin Wu; Qi Jiang; Qi Wang; Yue Zhang; Lian Duan; Jing Hu; Qiuming Li; Lei Lei; Zhiyan Shan
Journal:  J Mol Histol       Date:  2022-07-23       Impact factor: 3.156

3.  AAVvector-mediated in vivo reprogramming into pluripotency.

Authors:  Elena Senís; Lluc Mosteiro; Stefan Wilkening; Ellen Wiedtke; Ali Nowrouzi; Saira Afzal; Raffaele Fronza; Henrik Landerer; Maria Abad; Dominik Niopek; Manfred Schmidt; Manuel Serrano; Dirk Grimm
Journal:  Nat Commun       Date:  2018-07-09       Impact factor: 14.919

4.  Overexpression of the transcription factors OCT4 and KLF4 improves motor function after spinal cord injury.

Authors:  Xianpeng Huang; Chenggui Wang; Xiaopeng Zhou; Jingkai Wang; Kaishun Xia; Biao Yang; Zhe Gong; Liwei Ying; Chao Yu; Kesi Shi; Jiawei Shu; Feng Cheng; Bin Han; Chengzhen Liang; Fangcai Li; Qixin Chen
Journal:  CNS Neurosci Ther       Date:  2020-05-25       Impact factor: 5.243

5.  In vivo conversion of rat astrocytes into neuronal cells through neural stem cells in injured spinal cord with a single zinc-finger transcription factor.

Authors:  Masoumeh Zarei-Kheirabadi; Mahdi Hesaraki; Sahar Kiani; Hossein Baharvand
Journal:  Stem Cell Res Ther       Date:  2019-12-16       Impact factor: 6.832

6.  Functional Genomic Screening During Somatic Cell Reprogramming Identifies DKK3 as a Roadblock of Organ Regeneration.

Authors:  Frank Arnold; Pallavi U Mahaddalkar; Johann M Kraus; Xiaowei Zhong; Wendy Bergmann; Dharini Srinivasan; Johann Gout; Elodie Roger; Alica K Beutel; Eugen Zizer; Umesh Tharehalli; Nora Daiss; Ronan Russell; Lukas Perkhofer; Rupert Oellinger; Qiong Lin; Ninel Azoitei; Frank-Ulrich Weiss; Markus M Lerch; Stefan Liebau; Sarah-Fee Katz; André Lechel; Roland Rad; Thomas Seufferlein; Hans A Kestler; Michael Ott; Amar Deep Sharma; Patrick C Hermann; Alexander Kleger
Journal:  Adv Sci (Weinh)       Date:  2021-05-13       Impact factor: 16.806

Review 7.  From cancer to rejuvenation: incomplete regeneration as the missing link (part II: rejuvenation circle).

Authors:  Mamuka G Baramiya; Eugene Baranov; Irina Saburina; Lev Salnikov
Journal:  Future Sci OA       Date:  2020-06-30

Review 8.  Pharmacological Regulation of Oxidative Stress in Stem Cells.

Authors:  Jungwoon Lee; Yee Sook Cho; Haiyoung Jung; Inpyo Choi
Journal:  Oxid Med Cell Longev       Date:  2018-09-30       Impact factor: 6.543

9.  Human adult pluripotency: Facts and questions.

Authors:  Luminita Labusca; Kaveh Mashayekhi
Journal:  World J Stem Cells       Date:  2019-01-26       Impact factor: 5.326

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.